Evaluation of denaturing high-performance liquid chromatography (DHPLC) in the screening of mutations in hemophilia B patients [5]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 12, 2004, Pages 2267-2269

  Herbert, O ^a   Trossaert M ^a   Boisseau, P ^a   Fressinaud, E ^a   Gerson, F ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Inst de Genet Nantes Atlantique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; DNA FRAGMENT; GENOMIC DNA;

BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE IDENTIFICATION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; HEMOPHILIA B; HUMAN; LETTER; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SEQUENCE ANALYSIS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMOSOMES, HUMAN, X; COHORT STUDIES; DNA; FACTOR IX; FEMALE; GENOTYPE; HEMOPHILIA B; HUMANS; MALE; MASS SCREENING; MUTATION; POLYMERASE CHAIN REACTION;

EID: 13244298313     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.01019.x     Document Type: Letter

References (10)

1. Thompson AR. Structure, function, and molecular defects of factor IX. Blood 1986; 67: 565-72.
2. Anson DS, Choo KH, Rees DJ, Giannelli F, Gould K, Huddleston JA, Brownlee GG. The gene structure of human anti-haemophilic factor IX. EMBO J 1984; 3: 1053-60.
3. Xiao W, Oefner PJ. Denaturing high-performance liquid chromatography: a review. Hum Mutat 2001; 17: 439-74.
4. Oefner PJ, Underhill PA. Comparative DNA sequence by denaturing high performance liquid chromatography (DHPLC). Am J Hum Genet 1995; 57: A266.
5. McGraw RA, Davis LM, Noyes CM, Lundblad RL, Roberts HR, Graham JB, Stafford DW. Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX. Proc Natl Acad Sci USA 1985; 82: 2847-51.
6. Jones AC, Sampson JR, Cheadle JP. Low level mosaicism detectable by DHPLC but not by direct sequencing. Hum Mutat 2001; 17: 233-4.
7. Emmerson P, Maynard J, Jones S, Butler R, Sampson JR, Cheadle JP. Characterizing mutations in samples with low-level mosaicism by collection and analysis of DHPLC fractionated heteroduplexes. Hum Mutat 2003; 21: 112-5.
8. Castaldo G, Nardiello P, Bellitti F, Rocino A, Coppola A, di Minno G, Salvatore F. Denaturing HPLC procedure for factor IX gene scanning. Clin Chem 2003; 49: 815-8.
9. Costa JM, Vidaud D, Laurendeau I, Vidaud M, Fressinaud E, Moisan JP, David A, Meyer D, Lavergne JM. Somatic mosaicism and compound heterozygosity in female hemophilia B. Blood 2000; 96: 1585-7.
10. Liu JZ, Li X, Drost J, Thorland EC, Liu Q, Lind T, Roberts S, Wang HY, Sommer SS. The human factor IX gene as germline mutagen test: samples from Mainland China have the putatively endogenous pattern of mutation. Hum Mutat 2000; 16: 31-6.